Biosimilar

In this edition, macular retinal nerve fiber layer thickness linked with cognitive decline; FDA approves Lucentis biosimilar; advanced visual field loss risk higher after glaucoma diagnosis in Black patients; and more.

The FDA has approved a citrate-free, 100 mg/mL formulation of the Humira biosimilar Hadlima, according to a statement released by Samsung Bioepis and Organon.

Correctly identifying cytokine pathways that are dysregulated in any given rheumatology patient could lead to better use of current biologic therapies, said a presenter at the 2022 Association of Women in Rheumatology annual conference.

A denosumab biosimilar candidate demonstrated noninferior efficacy to its reference product, with similar safety profile, in postmenopausal patients with osteoporosis, according to data published in Arthritis Research & Therapy.

A novel biosimilar for adalimumab was associated with bio-equivalent pharmacokinetics and safety as the reference product in patients with moderate to severe plaque psoriasis, according to study findings.

ORLANDO — Despite the glacial pace of biosimilar uptake in the United States so far, their use is expected to cut drug costs by $54 billion over the next decade, noted a presenter at the 2022 Rheumatology Nurses Society Conference.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Allison W. Shuren, JD, MSN.

Poor physical performance measures in older men predicted their mortality risk after a bone fracture. It was the top story in endocrinology last week.

Among adults with type 2 diabetes, biosimilar insulin was noninferior to insulin glargine for lowering HbA1c, had similar safety and cost less, although not significantly, according to data.

NEW ORLEANS — Biosimilar products could reduce the cost of insulin for people with diabetes, but more manufacturers must enter the market to create competition and allow cost savings to be realized, according to a speaker.